SeQuent

SeQuent Scientific Limited is a global animal health company established in 2002, dedicated to the development, manufacturing, and supply of veterinary pharmaceutical products and services. Operating across the entire animal health value chain, the company provides active pharmaceutical ingredients (APIs) and finished dosage formulations. SeQuent also offers analytical and technical services, contributing to the health and well-being of livestock, poultry, and companion animals worldwide. Its industry focus spans Pharmaceuticals and Healthcare, positioning it as a key player in the veterinary medicine sector.

With a significant operational footprint, SeQuent Scientific Limited manages 5 locations and employs between 1,000 and 5,000 individuals. The company's revenue reached $128.2M, underscoring its substantial market presence. SeQuent's product portfolio includes scientific and limited services, catering to diverse veterinary needs. The company's commitment to quality and innovation drives its manufacturing processes and service offerings, ensuring compliance with global standards. Its strategic approach to business development and market penetration is evident in its operational scale and reach.

SeQuent Scientific Limited competes within a dynamic global animal health market. While specific competitors are not detailed, the company's focus on APIs and formulations places it alongside other major pharmaceutical entities. Its presence in Asia, specifically India, highlights its regional strength and international expansion efforts. The company's operational structure and strategic direction are supported by its dedicated workforce. To understand the human capital driving these advancements, one can Meet SeQuent's team for insights into their leadership and expertise. The company's hashtags indicate a broad range of operational and functional areas, including engineering, IT,View more...